Understanding Options Activity for Viking Therapeutics (VKTX)
Insights into the Options Trading of Viking Therapeutics
Investors with substantial capital are showcasing a strong bullish outlook on Viking Therapeutics.
By examining the options history for Viking Therapeutics (NASDAQ: VKTX), we’ve identified 13 trades that give us insight into market sentiment.
Analyzing these trades reveals that around 69% of the investors adopted a bullish stance, while 30% favored bearish positions.
Out of the total trades, there are 6 puts valued at approximately $453,915 and 7 calls amounting to $500,554.
Forecasted Price Range for VKTX
Recent trading activities suggest that key investors are targeting a price range between $20.00 and $100.00 for Viking Therapeutics over the past three months.
Examining Volume and Open Interest Trends
Monitoring volume and open interest is crucial when engaging in options trading. This information helps assess the liquidity and demand for Viking Therapeutics's options at specific strike prices. In the last 30 days, we can analyze the volume and open interest for all trades related to Viking Therapeutics, particularly within the targeted strike price range of $20.00 to $100.00.
Overview of Call and Put Volume for the Past 30 Days
In this period, we've observed active engagement in options trading for Viking Therapeutics, confirming sustained interest amongst investors.
Significant Options Activity
Detailed below is a breakdown of notable options trades for Viking Therapeutics:
Symbol: VKTX
Put/Call: Call
Trade Type: Sweep
Sentiment: Bullish
Expiration Date: 01/16/26
Ask Price: $7.20
Bid Price: $7.00
Trade Price: $7.20
Strike Price: $35.00
Total Trade Value: $160.5K
Open Interest: 1.3K
Volume: 297
Symbol: VKTX
Put/Call: Put
Trade Type: Sweep
Sentiment: Bullish
Expiration Date: 03/21/25
Ask Price: $1.43
Bid Price: $1.42
Trade Price: $1.42
Strike Price: $25.00
Total Trade Value: $142.1K
Open Interest: 216
Volume: 1.0K
Symbol: VKTX
Put/Call: Put
Trade Type: Sweep
Sentiment: Bullish
Expiration Date: 03/21/25
Ask Price: $1.85
Bid Price: $1.43
Trade Price: $1.44
Strike Price: $25.00
Total Trade Value: $141.6K
Open Interest: 216
Volume: 2.6K
Symbol: VKTX
Put/Call: Call
Trade Type: Trade
Sentiment: Bullish
Expiration Date: 03/21/25
Ask Price: $1.05
Bid Price: $0.99
Trade Price: $1.05
Strike Price: $35.00
Total Trade Value: $105.0K
Open Interest: 6.0K
Volume: 199
Symbol: VKTX
Put/Call: Put
Trade Type: Sweep
Sentiment: Bearish
Expiration Date: 03/21/25
Ask Price: $1.85
Bid Price: $1.46
Trade Price: $1.46
Strike Price: $25.00
Total Trade Value: $57.1K
Open Interest: 216
Volume: 2.6K
About Viking Therapeutics
Viking Therapeutics Inc is a forward-thinking healthcare service provider specializing in biopharmaceutical development. The company focuses particularly on metabolic and endocrine disorders, boasting a robust clinical pipeline including VK2809, VK5211, and VK0214. The first two are selective agonists of the thyroid hormone receptor beta, while VK5211 is a non-steroidal selective androgen receptor modulator.
Current Market Position of Viking Therapeutics
- With an active trading volume of 4,281,250, VKTX has seen a decline of 3.94%, currently priced at $28.05.
- The current Relative Strength Index (RSI) suggests the stock may be trending towards an oversold condition.
- The upcoming earnings report is anticipated within the next 57 days.
Analyst Recommendations for Viking Therapeutics
In the previous month, 5 analysts have analyzed this stock, establishing an average price target of $81.20. Notably:
- An analyst from Maxim Group has reaffirmed a Buy rating for Viking Therapeutics, setting a price target of $70.
- Citigroup downgraded its action to Neutral, altering the price target to $38.
- Raymond James maintained a Strong Buy rating, proposing a price target of $125.
- Scotiabank adjusted its rating to Sector Outperform, now targeting $102.
- Piper Sandler keeps an Overweight stance with a price target of $71.
Engaging in options trading involves both elevated risks and potential rewards. Prudent traders navigate these challenges by continually enhancing their knowledge, adapting strategies, and monitoring various market indicators actively. You can stay updated on the latest Viking Therapeutics options trading dynamics through real-time alerts.
Frequently Asked Questions
What is Viking Therapeutics?
Viking Therapeutics Inc is a healthcare company focused on developing treatments for metabolic and endocrine disorders.
What does the recent options activity indicate?
The options activity suggests a bullish sentiment among significant investors for Viking Therapeutics.
What is the current stock price of VKTX?
As of the latest update, VKTX is priced at $28.05, reflecting a decrease of 3.94%.
What is the forecasted price range for VKTX?
Key investors are targeting a price range of $20.00 to $100.00 for VKTX based on recent trading.
What are analysts saying about VKTX?
Analysts have varying predictions, with average price targets ranging from $38 to $125, indicating a mix of opinions on its future performance.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
